Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis
Open Access
- 1 February 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (2) , 653-657
- https://doi.org/10.1128/aac.47.2.653-657.2003
Abstract
The bactericidal activities of ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, and gatifloxacin were tested in three models of rifampin-tolerant Mycobacterium tuberculosis persisters. Model 1 was a 100-day-old, unshaken, anaerobically adapted culture in which serial dilutions of the quinolones were incubated for 5 days and CFU counts were then done In models 2 and 3, 100 mg of rifampin/liter was added to the 100-day culture for 5 or 7 days to produce tolerant organisms that did not grow on plates; the rifampin was then washed off, fresh medium was added to allow recovery of growth on plates, and the culture was incubated for 7 days before CFU counts. In model 2, the quinolones were added after rifampin had been washed off, whereas in model 3 the quinolones were added to the cultures containing rifampin. In models 1 and 2, ciprofloxacin had the least bactericidal activity, ofloxacin and levofloxacin had greater activities, and moxifloxacin and gatifloxacin had the greatest activities. In model 3, ofloxacin had no detectable activity whereas moxifloxacin killed about log10 0.279 CFU of the persisters per ml at concentrations attainable in lesions; isoniazid had virtually no activity. These findings predict that ofloxacin will not be found to have effective sterilizing activity in clinical studies now planned whereas moxifloxacin will be able to shorten treatment.Keywords
This publication has 16 references indexed in Scilit:
- The future challenges facing the development of new antimicrobial drugsNature Reviews Drug Discovery, 2002
- In Vitro and In Vivo Activities of Gatifloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2002
- Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in MiceAntimicrobial Agents and Chemotherapy, 2001
- Increased levels ofsigJmRNA in late stationary phase cultures ofMycobacterium tuberculosisdetected by DNA array hybridisationFEMS Microbiology Letters, 2001
- The Need for New Drugs against TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Foreword from the Co-Editor-in-ChiefTuberculosis, 2001
- Detection of mRNA Transcripts and Active Transcription in Persistent Mycobacterium tuberculosis Induced by Exposure to Rifampin or PyrazinamideJournal of Bacteriology, 2000
- The Early Bactericidal Activity of Ciprofloxacin in Patients with Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in miceAntimicrobial Agents and Chemotherapy, 1993
- Understanding the chemotherapy of tuberculosis—current problemsJournal of Antimicrobial Chemotherapy, 1992